Niclosamide, an oral anti-helminthic drug, suppresses macrophage-induced inflammation via STAT3 and/or NF-κB signaling and has been identified as a potent androgen receptor splice variant 7 (AR-V7) inhibitor in PCa cells [189]. The gene discussed is NFKB1; the disease is posterior cortical atrophy.